Latest Conference Coverage

NeuroPace RNS System Shows Improvements Over 9-Year Period

The largest and longest prospective neuromodulation trial in the field of epilepsy showed about a 75% response rate with patients achieving at least a 50% reduction in seizures.

Robert S. Fisher, MD, PhD: What Will an Epilepsy Physician Be Doing in the Future?

The Director of the Stanford Epilepsy Center discussed the current activities of epileptologists and considered how this might change in the near future, given advancing technology.

Lynn Liu, MD: When Should We Measure Antiepileptic Blood Levels?

The associate professor of neurology at the University of Rochester shared some of her advice for treating patients with epilepsy and focusing on the patient.

Does CBD's Approval Mark a Turning Point for Treatments in Dravet Syndrome?

The director of the Epilepsy Program at Children’s Hospital of Philadelphia spoke about the long-awaited advancement brought on by cannabidiol for Dravet syndrome.

Diazepam Buccal Soluble Film Formulation Shows Comparable Exposure Across Seizure Periods

This novel dosage form of diazepam had comparable times to maximal concentration in both 2-hour and 4-hour timeframes.

Anup D. Patel, MD: Long-Term Use of CBD in Lennox-Gastaut Syndrome

The section chief of pediatric neurology at Nationwide Children’s Hospital and an associate professor of clinical pediatrics and neurology at The Ohio State University College of Medicine spoke about what the findings mean for patients.

CBD Shows Continued Safety Profile, Seizure Reductions in Open-Label Extension

The recently approved therapy remained generally well tolerated and improvements in overall condition in Subject/Caregiver Global Impression of Change scores.

Phenotyping as a Rational for Drug Development in Obstructive Sleep Apnea

The Professor of Medicine at the University of New South Wales highlighted the latest knowledge in sleep apnea phenotyping and its crucial role in the development of targeted pharmacotherapies to treat OSA.

David Kemlink, MD, PhD: Actigraphic Recordings in Rapid Eye Movement Sleep Behavior Disorder

Actigraphic recording from upper extremities show consistently more prominent sleep fragmentation in rapid eye movement sleep behavior disorder patients compared to other sleep diagnoses.

Improving Communication Between Patients With Migraine and Providers

The director of the MedStar Georgetown Headache Center discussed ways to improve the patient-provider relationship and how primary care can get involved.

Jessica Ailani, MD: Delving Deeper into the Status of Patients With Migraine

The director of the MedStar Georgetown University Hospital Headache Center stressed building a culture of teaching patients to be their own advocates and to build the relationship with the patient to better manage their migraines.

Jessica Ailani, MD: Continuing to Improve Acute Migraine Care

The director of the MedStar Georgetown University Hospital Headache Center discussed the development of acute care options for patients to improve their quality of life and the management of their condition.

Brian Grosberg, MD: Device Development in Migraine

The director of the Hartford Headache Center spoke about the trend toward device use in migraine treatment, and some of the reasons that may have prompted it.

Brian Grosberg, MD: Nerivio Migra Device for Acute Migraine Treatment

The director of the Hartford Healthcare Headache Center in Connecticut and lead investigator on the trial provided some insight into the study's findings.

Understanding Cluster Headache Diagnostically, Therapeutically

As the scientific grasp of it gets tighter, ensuring physicians have an understanding of the diagnosis of and treatment options for cluster headache becomes of utmost importance.

Nerivio Migra Device Shows Success in Acute Migraine Treatment

Theranica, its developer, noted that it has completed regulatory submission for the device to the FDA, and that if approved, it plans to commercialize the product by the end of 2019.

Ricardo Osorio, MD: Unanswered Questions About the Relationship Between Sleep, Alzheimer Disease

The associate professor at NYU Langone discussed several of the questions that remained unanswered about the relationship between sleep and Alzheimer disease.

Does Cannabis Have Potential Therapeutic Use in Migraine, Headache?

While studies support the use of cannabis for pain in adults, a lack of clinical data and an inability to perform studies has slowed the medical community’s understanding of the drug’s conceivable use in headache conditions.

Asher J. Albertson, MD, PhD: Getting Interventions to Stroke Patients

Albertson discussed this facet of stroke care, and all the things being done outside just the clinic to help improve outcomes.

Ricardo Osorio, MD, on the Association Between Sleep-Wake Disruptions, Pathogenesis of Alzheimer

The associate professor at NYU Langone discussed emerging evidence that suggests that sleep disruption results in higher levels of markers associated with Alzheimer disease.

Ethical Issues Raised by Novel Therapies

The Carolyn and Matthew Bucksbaum Professor of Clinical Ethics at the University of Chicago spoke about the ethical considerations of spinal muscular atrophy and its treatment.

Ari Green, MD, MCR: Remyelination in Multiple Sclerosis

The medical director of the UCSF Multiple Sclerosis Center discussed the idea behind remyelination and shared his thoughts on what the best shot at developing a therapy might be.

Costantino Iadecola, MD: The Cost of Dementia's Increasing Prevalence

The Anne Parrish Titzell Professor of Neurology and Neuroscience at Weill Cornell Medicine’s Feil Family Brain and Mind Research Institute spoke about the cost the condition has for patients and their families.

Rolf Fronczek, PhD, MD: Cluster Headaches and Sleep

Recent work demonstrates that the anterior part of the hypothalamus is enlarged in cluster headache.

Claudia Testa, MD, PhD: Advancements Made in Huntington Disease Treatment

The professor of neurology at Virginia Commonwealth University discussed all the progress that’s been made in the space and shared her thoughts on the advances.

Addressing Cognitive Issues In Patients With Epilepsy

Cognitive complaints remain a major issue for patients with epilepsy, leading the epileptologist at the University of Pennsylvania to share her insight into addressing them.

Joshua Cohen, MD: Fremanezumab's Impact on Quality of Life and Comorbidities

The Global Medical Lead for Migraine and Headache at Teva Pharmaceuticals provided insight into how fremanezumab has helped to improve these facets of the condition.

Rolf Fronczek, PhD, MD: Narcolepsy and Opiates

The neurologist discussed an analysis of findings suggesting that opiate agonists may have a role in the treatment of narcolepsy.

Epilepsy, the Perfect Paradigm in Implementing Telemedicine

The clinical professor in pediatric neurology and director of regional neurology services at Children's Hospital Colorado shared her thoughts on why epilepsy is the perfect paradigm to implement telemedicine.

Robert J. Fox, MD: Treating Progressive Multiple Sclerosis

The neurologist from Cleveland Clinic discussed the challenges of treating progressive MS, and shared his clinical experience with ibudilast.